# Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

> **NCT00655616** · NA · COMPLETED · sponsor: **University of Dundee** · enrollment: 64 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Montelukast Placebo
- **DRUG:** Salmeterol, Montelukast

## Key facts

- **NCT ID:** NCT00655616
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655616, "Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00655616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*